DVM-PhD from Utrecht University, The Netherlands. Developed human vaccines in Bilthoven, The Netherlands for 15 years, gaining expertise in pre-clinical, assay development, process development. Since 2016, I have been managing director of Virtuvax BV, aiming to develop and make available new vaccine technologies. The model that Virtuvax exploits is to assemble parties being institutes, SMEs, large companies or governmental bodies that have the necessary technologies and expertise to launch a specific vaccine.